Description
Pharmaceutical Name: LETROZOLE 2.5®
Chemical name: 4,4′-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
LETROZOLE 2.5® is indicated in treatment of breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy or as initial treatment of hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer.
| LETROZOLE 2.5® | |
|---|---|
|
Potency
|
2.5mg/tablet
|
|
Appearance
|
Metallic Gold Color Hexagon shaped tablet
|
|
Dosage
|
2.5 mg EOD/Cycle
|
Reviews
There are no reviews yet.